Amgen to stop making EPO

Amgen the company that manufactures Epogen, otherwise known as EPO is to scale down and eventually stop production of the drug over the next twelve months.
Epogen is a legitimate medical treatment that increases the red blood cells in patients with certain cancers and kidney disease.
Used illegally by pro cyclists and other athletes, it also increase red blood cells, thereby carrying more oxygen to the muscles, resulting in a huge boost in performance.
I have always found it interesting and fascinating that Amgen sponsors the Tour of California professional bike race each year.
Is this a mere coincidence? At what board meeting did someone suggest that a company that makes medication for very sick people would benefit, and boost sales by sponsoring a professional bike race?
Amgen, based in Longmont, California is shutting down production of Epogen because of a steady decrease in sales over recent years. Figures went from 2.6 billion in 2009, to 2.5 billion in 2010, to 2 billion in 2011. (Note that is Billion with a “B.”) The decline in sales is still falling with current quarterly earnings down 3% on last year’s sales.
I am not speculating as to why Amgen’s sale of Epogen is declining, I am simply asking why? Are there less sick people needing the drug, because that is not how patterns in a population’s health usually go. There may be fluctuations up and down from one year to the next, but not usually a steady decline.
Is it yet another coincidence that sales have declined since 2009, over the same period that professional cycling started to clean up its act? And is it possible that illegal sales of EPO could run into Billions with a “B?”
These are simply questions I am asking. I do not have the time or resources to follow up on this story. But it would be interesting to go into Amgen’s financial records and follow the money trail, and find out where all that Epogen went.




Looking forward to the TDF
I have watched some great racing this year, the Spring Classics, the Giro d’Italia, and the lead up races to the Tour de France. The Paris/Niece, the Criterium du Dophine, the Route du Sud, and the Tour de Suisse. I have not written a single word about any of them here on my blog.
The reason, whenever I do it turns into a discussion on doping, and quite honestly if I am in the middle of watching a race, or I have just watched it, it spoils it for me. It is not that I am in denial, or that I am so naïve to believe that doping doesn’t still go on, but I do believe that the sport is in a better place than it has been for a long time.
The fact that no one rider is dominating the sport anymore, I feel is an indication of that. It makes for better and more interesting racing. Here we are approaching the Tour de France, with four favorites. Contador, Froome, Quintana, and Nibali.
The winner will be whoever hits peak form during the race, so don’t rule out Tejay Van Garderen. Sure Froome beat him in the Criterium du Dophine, but only by 10 seconds. And if Tejay peaks at the Tour that could change. Nibali did nothing in the same race, but then again he did the exact same thing last year but appeared to peak at the Tour.
The same goes for French riders Thibault Pinot and Warren Barguil, and young British rider Simon Yates. Any of these could peak at the right time and cause an upset. All are in with at least a chance of a podium place.
Froome has a good chance of winning if he doesn’t fall off his bike. But I would take bets on him falling off over winning. I read a quote somewhere, that Chris Froome’s riding style is like “An octopus falling from a tree.” Not a pleasing rider to watch. Sure he gets the job done, but Contador climbing out of the saddle is more like watching a ballet, and a joy to behold.
Contador has the Giro d’Italia in his legs, which could either help or hinder his chances, depending on whether or not he has taken all the right steps to recover. On the penultimate stage of the Route du Sud that included three category one climbs, Contador looked extremely strong, but Quintana was able to meet his every attack. In the end it was Contador’s superior bike handling skills on the final descent that won him the stage and the overall race.
I would like to see Contador win, if only to see him pull of the Giro/Tour double. He will almost certainly retire at the end of this year if he does. He is a joy to watch, and tough as nails, remember he dislocated a shoulder in a crash in this year’s Giro, and carried on to win. Quintana could win too, Froomey and Nibali I could care less really.
So let’s have all the anti-doping rhetoric now while I have a week to forget about it. Then I can sit back and enjoy the racing. It promises to be a great one.
To Share click "Share Article" below